Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients

被引：0
|
作者：
Kessarin Thanapirom
Sirinporn Suksawatamnuay
Wattana Sukeepaisarnjaroen
Pisit Tangkijvanich
Sombat Treeprasertsuk
Panarat Thaimai
Rujipat Wasitthankasem
Yong Poovorawan
Piyawat Komolmit
机构：
[1] Chulalongkorn University,Divisions of Gastroenterology, Department of Medicine, Faculty of Medicine
[2] King Chulalongkorn Memorial Hospital,Center of Excellence in Liver Diseases
[3] Thai Red Cross Society,Gastroenterology unit, Department of Medicine, Srinagarind Hospital, Faculty of Medicine
[4] King Chulalongkorn Memorial Hospital,Department of Biochemistry, Faculty of Medicine
[5] Thai Red Cross Society,Center of Excellence in Clinical Virology Department of Pediatrics, Faculty of Medicine
[6] Khon Kaen University,undefined
[7] Chulalongkorn University,undefined
[8] Chulalongkorn University,undefined
来源：
BMC Gastroenterology | / 17卷
关键词：
Chronic hepatitis C virus infection; Vitamin D; Gene polymorphisms; Pegylated interferon;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis
    Kitson, Matthew T.
    Sarrazin, Christoph
    Toniutto, Pierluigi
    Eslick, Guy D.
    Roberts, Stuart K.
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1247 - 1252
  • [32] Equally Poor Outcomes to Pegylated Interferon-based Therapy in African Americans and Hispanics With Chronic Hepatitis C Infection
    Satapathy, Sanjaya K.
    Lingisetty, Chandra Sekhar
    Proper, Shawnette
    Chaudhari, Shobhana
    Williams, Susan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (02) : 140 - 145
  • [33] PREDICTORS OF SUSTAINED RESPONSE TO INTERFERON-BASED THERAPY IN CHRONIC HEPATITIS B
    Jelev, Deian
    Antonov, Krasimir
    Ivanova, Aneta
    Krastev, Zahariy
    JOURNAL OF IMAB, 2011, 17 (01): : 154 - 157
  • [34] Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives
    De Re, Valli
    HEPATITIS MONTHLY, 2010, 10 (03) : 231 - 232
  • [35] Interferon-based therapy for chronic hepatitis C: current and future perspectives
    Stefan Zeuzem
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 610 - 622
  • [36] Interferon-based therapy for chronic hepatitis C: current and future perspectives
    Zeuzem, Stefan
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (11): : 610 - 622
  • [37] Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C
    Koksal, I
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (03) : 491 - 494
  • [38] Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D
    Abbas, Zaigham
    Yakoob, Javed
    Umer, Muhammad A.
    Abbas, Minaam
    Hamid, Saeed
    ANTIVIRAL THERAPY, 2015, 20 (05) : 529 - 533
  • [39] LIVER GENE EXPRESSION SIGNATURE TO PREDICT RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C
    Duces, A.
    Bieche, I.
    Jardin-Watelet, B.
    Lapalus, M.
    De Muynck, S.
    Dupas, E.
    Molina, I.
    Lambert, N.
    Nicolas, E.
    Sallenave, B.
    Estrabaud, E.
    Jullian, N.
    Martinot-Peignoux, M.
    Lada, O.
    Paradis, V.
    Valla, D.
    Bedossa, P.
    Laune, D.
    Vidaud, M.
    Marcellin, P.
    Asselah, T.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S266 - S267
  • [40] Liver Gene Expression Signature to Predict Response to Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C
    Duces, A.
    Bieche, Ivan
    Jardin-Watelet, Benedicte
    Lapalus, M.
    De Muynck, S.
    Dupas, Eve
    Molina, Isabelle
    Lambert, N.
    Nicolas, E.
    Sallenave, B.
    Estrabaud, E.
    Jullian, Nathalie
    Martinot-Peignoux, M.
    Lada, Olivier
    Paradis, V.
    Valla, Dominique
    Bedossa, Pierre
    Laune, Daniel
    Vidaud, M.
    Marcellin, Patrick
    Asselah, T.
    GASTROENTEROLOGY, 2010, 138 (05) : S846 - S846
12345